These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4046915)

  • 1. Investigation and treatment of renal calculi.
    Evans RA; Maher PO; Agostino M; Wong SY; Marel GM; Hills E
    Med J Aust; 1985 Sep; 143(7):278-81. PubMed ID: 4046915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A clinical study of urolithiasis in Shizuoka City Hospital--stone analysis and 24-hour urine calcium and uric acid levels].
    Kanamaru H; Sasaki M; Ohshiro K; Komatz Y
    Hinyokika Kiyo; 1985 Jun; 31(6):915-20. PubMed ID: 4061209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of renal calculi.
    Coe FL; Favus MJ
    Adv Intern Med; 1980; 26():373-92. PubMed ID: 7013442
    [No Abstract]   [Full Text] [Related]  

  • 4. New drug therapy for kidney stones: a review of cellulose sodium phosphate, acetohydroxamic acid, and potassium citrate.
    Lake KD; Brown DC
    Drug Intell Clin Pharm; 1985; 19(7-8):530-9. PubMed ID: 3896714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graphic display of urinary risk factors for renal stone formation.
    Pak CY; Skurla C; Harvey J
    J Urol; 1985 Nov; 134(5):867-70. PubMed ID: 4057368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiology, diagnosis and conservative therapy of non-calcium kidney calculi].
    Hochreiter W; Knoll T; Hess B
    Ther Umsch; 2003 Feb; 60(2):89-97. PubMed ID: 12649987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of patients with staghorn calculi in our experience.
    Akagashi K; Tanda H; Kato S; Ohnishi S; Nakajima H; Nanbu A; Nitta T; Koroku M; Sato Y; Hanzawa T
    Int J Urol; 2004 May; 11(5):276-81. PubMed ID: 15147542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of kidney stone composition in the detection of metabolic abnormalities.
    Pak CY; Poindexter JR; Adams-Huet B; Pearle MS
    Am J Med; 2003 Jul; 115(1):26-32. PubMed ID: 12867231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of blood tests in screening for metabolic disorders in kidney stone disease.
    Eyre KS; Lewis F; Cui H; Grout E; Mihai R; Turney BW; Howles SA
    BJU Int; 2021 May; 127(5):538-543. PubMed ID: 32967050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension in kidney stone patients.
    Cupisti A; Morelli E; Meola M; Cozza V; Parrucci M; Barsotti G
    Nephron; 1996; 73(4):569-72. PubMed ID: 8856253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney stones.
    Parmar MS
    BMJ; 2004 Jun; 328(7453):1420-4. PubMed ID: 15191979
    [No Abstract]   [Full Text] [Related]  

  • 13. Preventing kidney stones: calcium restriction not warranted.
    Hall PM
    Cleve Clin J Med; 2002 Nov; 69(11):885-8. PubMed ID: 12430973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical approach to nephrolithiasis.
    Kupin WL
    Hosp Pract (Off Ed); 1995 Mar; 30(3):57-60, 63-4, 66; quiz 93. PubMed ID: 7883810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between causes and composition of urinary stones.
    Otnes B
    Scand J Urol Nephrol; 1983; 17(1):93-8. PubMed ID: 6346479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The composition and quantitative analysis of urinary calculi in patients with renal calculi.
    Jawalekar S; Surve VT; Bhutey AK
    Nepal Med Coll J; 2010 Sep; 12(3):145-8. PubMed ID: 21446361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urinary excretion and serum concentration of calcium, magnesium, sodium and phosphate in male patients with recurring renal stone formation.
    Jorgensen FS
    Scand J Urol Nephrol; 1975; 9(3):243-8. PubMed ID: 1209181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced glomerular filtration rate and hypercalciuria in primary struvite nephrolithiasis.
    Kristensen C; Parks JH; Lindheimer M; Coe FL
    Kidney Int; 1987 Nov; 32(5):749-53. PubMed ID: 3430961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of bendroflumethiazide on the renal handling of calcium, magnesium and phosphate in normocalcaemic renal stone formers and in hyperparathyroidism.
    Jorgensen FS; Transbol I
    Acta Med Scand; 1973 Oct; 194(4):327-34. PubMed ID: 4749172
    [No Abstract]   [Full Text] [Related]  

  • 20. Predisposing factors and prevention of renal calculi.
    Cargill JG; Burns JR
    Compr Ther; 1986 Dec; 12(12):43-9. PubMed ID: 3791932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.